147 related articles for article (PubMed ID: 1680650)
1. Stereoselective metabolism of carvedilol in the rat. Use of enantiomerically radiolabeled pseudoracemates.
Fujimaki M; Shintani S; Hakusui H
Drug Metab Dispos; 1991; 19(4):749-53. PubMed ID: 1680650
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of R(+)- and S(-)-carvedilol by rat liver microsomes. Evidence for stereoselective oxidation and characterization of the cytochrome P450 isozymes involved.
Fujimaki M
Drug Metab Dispos; 1994; 22(5):700-8. PubMed ID: 7835220
[TBL] [Abstract][Full Text] [Related]
3. Identification of two major biliary metabolites of carvedilol in rats.
Fujimaki M; Hakusui H
Xenobiotica; 1990 Oct; 20(10):1025-34. PubMed ID: 2082592
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective disposition and tissue distribution of carvedilol enantiomers in rats.
Fujimaki M
Chirality; 1992; 4(3):148-54. PubMed ID: 1586585
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective glucuronidation of carvedilol in human liver and intestinal microsomes.
Hanioka N; Tanaka S; Moriguchi Y; Narimatsu S
Pharmacology; 2012; 90(3-4):117-24. PubMed ID: 22814440
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound.
Neugebauer G; Akpan W; Kaufmann B; Reiff K
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S108-11. PubMed ID: 1974498
[TBL] [Abstract][Full Text] [Related]
7. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
8. Enantioselective metabolism and pharmacokinetics of Casodex in the male rat.
McKillop D; Simons PJ; Cockshott ID; Hill SJ; Harding JR; Cooper KJ; Jones DC
Xenobiotica; 1995 Jun; 25(6):623-33. PubMed ID: 7483662
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective disposition of carprofen, flunoxaprofen, and naproxen in rats.
Iwakawa S; Spahn H; Benet LZ; Lin ET
Drug Metab Dispos; 1991; 19(5):853-7. PubMed ID: 1686227
[TBL] [Abstract][Full Text] [Related]
10. Determination and Comparison of the Solubility, Oil-Water Partition Coefficient, Intestinal Absorption, and Biliary Excretion of Carvedilol Enantiomers.
Zhang Q; Wang X; Xue H; Huang B; Lin Z; Cai Z
AAPS PharmSciTech; 2021 Jan; 22(1):43. PubMed ID: 33426619
[TBL] [Abstract][Full Text] [Related]
11. Mutual inhibition between carvedilol enantiomers during racemate glucuronidation mediated by human liver and intestinal microsomes.
Takekuma Y; Yagisawa K; Sugawara M
Biol Pharm Bull; 2012; 35(2):151-63. PubMed ID: 22293344
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of the (+)-, (+/-)-, and (-)-enantiomers of alpha-methylfluorene-2-acetic acid (cicloprofen) in rats.
Dean AV; Lan SJ; Kripalani KJ; Difazio LT; Schreiber EC
Xenobiotica; 1977 Sep; 7(9):549-60. PubMed ID: 602253
[TBL] [Abstract][Full Text] [Related]
13. Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry.
Poggi JC; Da Silva FG; Coelho EB; Marques MP; Bertucci C; Lanchote VL
Chirality; 2012 Mar; 24(3):209-14. PubMed ID: 22271587
[TBL] [Abstract][Full Text] [Related]
14. Disposition of carvedilol enantiomers in patients with liver cirrhosis: evidence for disappearance of stereoselective first-pass extraction.
Neugebauer G; Gabor M; Reiff K
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S142-6. PubMed ID: 1378143
[TBL] [Abstract][Full Text] [Related]
15. Biliary excretion and enterohepatic cycling of R- and S-flurbiprofen in the rat.
Eeckhoudt SL; Evrard PA; Verbeeck RK
Drug Metab Dispos; 1997 Apr; 25(4):428-30. PubMed ID: 9107541
[TBL] [Abstract][Full Text] [Related]
16. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
[TBL] [Abstract][Full Text] [Related]
17. Assay and disposition of carvedilol enantiomers in humans and monkeys: evidence of stereoselective presystemic metabolism.
Fujimaki M; Murakoshi Y; Hakusui H
J Pharm Sci; 1990 Jul; 79(7):568-72. PubMed ID: 1975840
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective disposition of hydratropic acid in rat.
Yamaguchi T; Nakamura Y
Drug Metab Dispos; 1985; 13(5):614-9. PubMed ID: 2865113
[TBL] [Abstract][Full Text] [Related]
19. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
20. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
Lankford SM; Maskasame C; Bai SA
Drug Metab Dispos; 1994; 22(5):776-87. PubMed ID: 7835231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
